1 October 2021

The 4th Scientific Summit on Tobacco Harm Reduction: Novel products, Research & Policy was held virtually on the 29th & 30th of September 2021. This conference focuses on smoking control and harm reduction and attracts an audience of medical communities, science-minded people, and policymakers. Several sessions ranged in topics around the frequency of alternative tobacco product use among smokers and public health strategies.

The No Smoke Summit allows scientists and academics to present, discuss, and challenge recent data related to the benefits and risks associated with alternative tobacco product use among smokers. The program included topics on toxicology and aerosol chemistry as well as clinical assessment and harm reduction. 

Watch the presentations from PMI Scientists below:

A Japanese pharmacy study in cessation patients to explore the collection of tobacco use data to supplement real-world evidence

Angela van der Plas

Toxicological assessment of the aerosol generated by a novel pin-based heating system in human bronchial epithelial cells and organotypic small airway epithelial cultures

Shoaib Majeed

Aerosol from a heated tobacco product has less effect on liver detoxifying enzymes than cigarette smoke

David Bovard

Use of interrupted time series analysis for evaluating hospitalization rates before and after the introduction of heated tobacco products in the Japanese market

Angela van der Plas

Related Articles